Oral Supplementation of Parturient Mothers with Vitamin D and Its Effect on 25OHD Status of Exclusively Breastfed Infants at 6 Months of Age: A Double-Blind Randomized Placebo Controlled Trial
Exclusively breastfed infants are at increased risk of vitamin D deficiency and many lactating mothers have been found deficient in 25OHD stores. To compare serum vitamin D levels in exclusively breastfed infants at 6 months of age with or without oral supplementation of 600,000 IU of vitamin D3 to...
Gespeichert in:
| Veröffentlicht in: | Breastfeeding medicine 2017-12, Vol.12 (10), p.621-628 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 628 |
|---|---|
| container_issue | 10 |
| container_start_page | 621 |
| container_title | Breastfeeding medicine |
| container_volume | 12 |
| creator | Naik, Prasanna Faridi, M M A Batra, Prerna Madhu, S V |
| description | Exclusively breastfed infants are at increased risk of vitamin D deficiency and many lactating mothers have been found deficient in 25OHD stores.
To compare serum vitamin D levels in exclusively breastfed infants at 6 months of age with or without oral supplementation of 600,000 IU of vitamin D3 to mothers in early postpartum period.
Exclusively breastfeeding term parturient mothers were randomized 24-48 hours following delivery to receive either 600,000 IU of vitamin D3 (Cholecalciferol) over 10 days in a dose of 60,000 IU/day or placebo. 25OHD levels were measured by Radio Immuno Assay method at recruitment and after 6 months in all mothers and their infants. Urinary calcium and creatinine ratio was measured to monitor adverse effects of vitamin D3 in both mothers and infants at 14 weeks and 6 months of age. X-ray of both wrists in anteroposterior view and serum alkaline phosphatase of infants were done in both groups at 6 months of age to look for evidence of rickets.
Maternal profile was similar in intervention (A) and control (B) groups. Mothers' serum 25OHD levels at recruitment were also similar being 16.2 ± 9.3 ng/mL in group A and 14.1 ± 7.1 ng/mL in group B. After 6 months, 25OHD levels were 40.3 ± 21.6 and 22.9 ± 20.1 ng/mL in group A and group B mothers (p ≤ 0.00), respectively. The serum 25OHD levels in cord blood were 9.9 ± 5.7 and 8.9 ± 5.1 ng/mL, respectively, in infants born to mothers in intervention and control groups (p = 0.433). At 6 months of age, the serum 25OHD levels significantly (p |
| doi_str_mv | 10.1089/bfm.2016.0164 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1951561077</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1976080366</sourcerecordid><originalsourceid>FETCH-LOGICAL-c321t-22408e45b075323c35c968323db32a8f0b81844b3174121b96347edbc2d1fd653</originalsourceid><addsrcrecordid>eNpdkc1u1DAUhS0EoqWwZIsssWGTwT-xk7Cbzgy0UtFUtLCN7MRmXDnx4B-gPB2Pxh3asmBh-erqO58tHYReUrKgpO3eajstGKFyAad-hI6pELJqec0eP8xM8CP0LKUbQmoB0FN0xDrCmpY2x-j3NiqPr8p-781k5qyyCzMOFl-qmEt0sMIfQ96ZmPAPl3f4i8tqcjNeYzWP-DwnvLHWDBlDjInt2RpfgaSkg2Pzc_Alue_G3-LTaFTK1kBmtmqGnMpYgnvOu7_w8qt5h5d4HYr2pjr1DvSf4I0wuV-QuvRqMDrgFQRi8B5W19Ep_xw9scon8-L-PkGf32-uV2fVxfbD-Wp5UQ2c0VwxVpPW1EKTRnDGBy6GTrYwjZoz1VqiW9rWtea0qSmjupO8bsyoBzZSO0rBT9CbO-8-hm_FpNxPLg3GezWbUFJPO0GFpKRpAH39H3oTSpzhd0A1krSESwlUdUcNMaQUje330U0q3vaU9Idqe6i2P1TbH6oF_tW9tejJjP_ohy75H-vWnok</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1976080366</pqid></control><display><type>article</type><title>Oral Supplementation of Parturient Mothers with Vitamin D and Its Effect on 25OHD Status of Exclusively Breastfed Infants at 6 Months of Age: A Double-Blind Randomized Placebo Controlled Trial</title><source>Alma/SFX Local Collection</source><creator>Naik, Prasanna ; Faridi, M M A ; Batra, Prerna ; Madhu, S V</creator><creatorcontrib>Naik, Prasanna ; Faridi, M M A ; Batra, Prerna ; Madhu, S V</creatorcontrib><description>Exclusively breastfed infants are at increased risk of vitamin D deficiency and many lactating mothers have been found deficient in 25OHD stores.
To compare serum vitamin D levels in exclusively breastfed infants at 6 months of age with or without oral supplementation of 600,000 IU of vitamin D3 to mothers in early postpartum period.
Exclusively breastfeeding term parturient mothers were randomized 24-48 hours following delivery to receive either 600,000 IU of vitamin D3 (Cholecalciferol) over 10 days in a dose of 60,000 IU/day or placebo. 25OHD levels were measured by Radio Immuno Assay method at recruitment and after 6 months in all mothers and their infants. Urinary calcium and creatinine ratio was measured to monitor adverse effects of vitamin D3 in both mothers and infants at 14 weeks and 6 months of age. X-ray of both wrists in anteroposterior view and serum alkaline phosphatase of infants were done in both groups at 6 months of age to look for evidence of rickets.
Maternal profile was similar in intervention (A) and control (B) groups. Mothers' serum 25OHD levels at recruitment were also similar being 16.2 ± 9.3 ng/mL in group A and 14.1 ± 7.1 ng/mL in group B. After 6 months, 25OHD levels were 40.3 ± 21.6 and 22.9 ± 20.1 ng/mL in group A and group B mothers (p ≤ 0.00), respectively. The serum 25OHD levels in cord blood were 9.9 ± 5.7 and 8.9 ± 5.1 ng/mL, respectively, in infants born to mothers in intervention and control groups (p = 0.433). At 6 months of age, the serum 25OHD levels significantly (p < 0.00) raised to 29.1 ± 14.6 ng/mL in infants of group A compared to those of group B (15.7 ± 17.7 ng/mL). Four infants developed radiological rickets at 6 months of age, two infants each in intervention group and study group. As against 10 infants in the control group (16.94%), no infant in the study group had biochemical rickets. Urinary calcium and creatinine ratio in mothers and infants at 14 weeks and 6 months of age in both intervention and study group was within normal limits, indicating there was no adverse effects of oral administration of 600,000 IU of vitamin D3.
Serum 25OHD levels of exclusively breastfed infants significantly rise at 6 months of age when their mothers are orally supplemented with 60,000 IU of vitamin D3 daily for 10 days in the early postpartum period in comparison to infants of vitamin D3 unsupplemented mothers.</description><identifier>ISSN: 1556-8253</identifier><identifier>EISSN: 1556-8342</identifier><identifier>DOI: 10.1089/bfm.2016.0164</identifier><identifier>PMID: 29027817</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Age ; Breastfeeding & lactation ; Double-blind studies ; Evidence-based medicine ; Postpartum period ; Vitamin D ; Vitamin deficiency</subject><ispartof>Breastfeeding medicine, 2017-12, Vol.12 (10), p.621-628</ispartof><rights>(©) Copyright 2017, Mary Ann Liebert, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c321t-22408e45b075323c35c968323db32a8f0b81844b3174121b96347edbc2d1fd653</citedby><cites>FETCH-LOGICAL-c321t-22408e45b075323c35c968323db32a8f0b81844b3174121b96347edbc2d1fd653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29027817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Naik, Prasanna</creatorcontrib><creatorcontrib>Faridi, M M A</creatorcontrib><creatorcontrib>Batra, Prerna</creatorcontrib><creatorcontrib>Madhu, S V</creatorcontrib><title>Oral Supplementation of Parturient Mothers with Vitamin D and Its Effect on 25OHD Status of Exclusively Breastfed Infants at 6 Months of Age: A Double-Blind Randomized Placebo Controlled Trial</title><title>Breastfeeding medicine</title><addtitle>Breastfeed Med</addtitle><description>Exclusively breastfed infants are at increased risk of vitamin D deficiency and many lactating mothers have been found deficient in 25OHD stores.
To compare serum vitamin D levels in exclusively breastfed infants at 6 months of age with or without oral supplementation of 600,000 IU of vitamin D3 to mothers in early postpartum period.
Exclusively breastfeeding term parturient mothers were randomized 24-48 hours following delivery to receive either 600,000 IU of vitamin D3 (Cholecalciferol) over 10 days in a dose of 60,000 IU/day or placebo. 25OHD levels were measured by Radio Immuno Assay method at recruitment and after 6 months in all mothers and their infants. Urinary calcium and creatinine ratio was measured to monitor adverse effects of vitamin D3 in both mothers and infants at 14 weeks and 6 months of age. X-ray of both wrists in anteroposterior view and serum alkaline phosphatase of infants were done in both groups at 6 months of age to look for evidence of rickets.
Maternal profile was similar in intervention (A) and control (B) groups. Mothers' serum 25OHD levels at recruitment were also similar being 16.2 ± 9.3 ng/mL in group A and 14.1 ± 7.1 ng/mL in group B. After 6 months, 25OHD levels were 40.3 ± 21.6 and 22.9 ± 20.1 ng/mL in group A and group B mothers (p ≤ 0.00), respectively. The serum 25OHD levels in cord blood were 9.9 ± 5.7 and 8.9 ± 5.1 ng/mL, respectively, in infants born to mothers in intervention and control groups (p = 0.433). At 6 months of age, the serum 25OHD levels significantly (p < 0.00) raised to 29.1 ± 14.6 ng/mL in infants of group A compared to those of group B (15.7 ± 17.7 ng/mL). Four infants developed radiological rickets at 6 months of age, two infants each in intervention group and study group. As against 10 infants in the control group (16.94%), no infant in the study group had biochemical rickets. Urinary calcium and creatinine ratio in mothers and infants at 14 weeks and 6 months of age in both intervention and study group was within normal limits, indicating there was no adverse effects of oral administration of 600,000 IU of vitamin D3.
Serum 25OHD levels of exclusively breastfed infants significantly rise at 6 months of age when their mothers are orally supplemented with 60,000 IU of vitamin D3 daily for 10 days in the early postpartum period in comparison to infants of vitamin D3 unsupplemented mothers.</description><subject>Age</subject><subject>Breastfeeding & lactation</subject><subject>Double-blind studies</subject><subject>Evidence-based medicine</subject><subject>Postpartum period</subject><subject>Vitamin D</subject><subject>Vitamin deficiency</subject><issn>1556-8253</issn><issn>1556-8342</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpdkc1u1DAUhS0EoqWwZIsssWGTwT-xk7Cbzgy0UtFUtLCN7MRmXDnx4B-gPB2Pxh3asmBh-erqO58tHYReUrKgpO3eajstGKFyAad-hI6pELJqec0eP8xM8CP0LKUbQmoB0FN0xDrCmpY2x-j3NiqPr8p-781k5qyyCzMOFl-qmEt0sMIfQ96ZmPAPl3f4i8tqcjNeYzWP-DwnvLHWDBlDjInt2RpfgaSkg2Pzc_Alue_G3-LTaFTK1kBmtmqGnMpYgnvOu7_w8qt5h5d4HYr2pjr1DvSf4I0wuV-QuvRqMDrgFQRi8B5W19Ep_xw9scon8-L-PkGf32-uV2fVxfbD-Wp5UQ2c0VwxVpPW1EKTRnDGBy6GTrYwjZoz1VqiW9rWtea0qSmjupO8bsyoBzZSO0rBT9CbO-8-hm_FpNxPLg3GezWbUFJPO0GFpKRpAH39H3oTSpzhd0A1krSESwlUdUcNMaQUje330U0q3vaU9Idqe6i2P1TbH6oF_tW9tejJjP_ohy75H-vWnok</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Naik, Prasanna</creator><creator>Faridi, M M A</creator><creator>Batra, Prerna</creator><creator>Madhu, S V</creator><general>Mary Ann Liebert, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201712</creationdate><title>Oral Supplementation of Parturient Mothers with Vitamin D and Its Effect on 25OHD Status of Exclusively Breastfed Infants at 6 Months of Age: A Double-Blind Randomized Placebo Controlled Trial</title><author>Naik, Prasanna ; Faridi, M M A ; Batra, Prerna ; Madhu, S V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c321t-22408e45b075323c35c968323db32a8f0b81844b3174121b96347edbc2d1fd653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Age</topic><topic>Breastfeeding & lactation</topic><topic>Double-blind studies</topic><topic>Evidence-based medicine</topic><topic>Postpartum period</topic><topic>Vitamin D</topic><topic>Vitamin deficiency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Naik, Prasanna</creatorcontrib><creatorcontrib>Faridi, M M A</creatorcontrib><creatorcontrib>Batra, Prerna</creatorcontrib><creatorcontrib>Madhu, S V</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Breastfeeding medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Naik, Prasanna</au><au>Faridi, M M A</au><au>Batra, Prerna</au><au>Madhu, S V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral Supplementation of Parturient Mothers with Vitamin D and Its Effect on 25OHD Status of Exclusively Breastfed Infants at 6 Months of Age: A Double-Blind Randomized Placebo Controlled Trial</atitle><jtitle>Breastfeeding medicine</jtitle><addtitle>Breastfeed Med</addtitle><date>2017-12</date><risdate>2017</risdate><volume>12</volume><issue>10</issue><spage>621</spage><epage>628</epage><pages>621-628</pages><issn>1556-8253</issn><eissn>1556-8342</eissn><abstract>Exclusively breastfed infants are at increased risk of vitamin D deficiency and many lactating mothers have been found deficient in 25OHD stores.
To compare serum vitamin D levels in exclusively breastfed infants at 6 months of age with or without oral supplementation of 600,000 IU of vitamin D3 to mothers in early postpartum period.
Exclusively breastfeeding term parturient mothers were randomized 24-48 hours following delivery to receive either 600,000 IU of vitamin D3 (Cholecalciferol) over 10 days in a dose of 60,000 IU/day or placebo. 25OHD levels were measured by Radio Immuno Assay method at recruitment and after 6 months in all mothers and their infants. Urinary calcium and creatinine ratio was measured to monitor adverse effects of vitamin D3 in both mothers and infants at 14 weeks and 6 months of age. X-ray of both wrists in anteroposterior view and serum alkaline phosphatase of infants were done in both groups at 6 months of age to look for evidence of rickets.
Maternal profile was similar in intervention (A) and control (B) groups. Mothers' serum 25OHD levels at recruitment were also similar being 16.2 ± 9.3 ng/mL in group A and 14.1 ± 7.1 ng/mL in group B. After 6 months, 25OHD levels were 40.3 ± 21.6 and 22.9 ± 20.1 ng/mL in group A and group B mothers (p ≤ 0.00), respectively. The serum 25OHD levels in cord blood were 9.9 ± 5.7 and 8.9 ± 5.1 ng/mL, respectively, in infants born to mothers in intervention and control groups (p = 0.433). At 6 months of age, the serum 25OHD levels significantly (p < 0.00) raised to 29.1 ± 14.6 ng/mL in infants of group A compared to those of group B (15.7 ± 17.7 ng/mL). Four infants developed radiological rickets at 6 months of age, two infants each in intervention group and study group. As against 10 infants in the control group (16.94%), no infant in the study group had biochemical rickets. Urinary calcium and creatinine ratio in mothers and infants at 14 weeks and 6 months of age in both intervention and study group was within normal limits, indicating there was no adverse effects of oral administration of 600,000 IU of vitamin D3.
Serum 25OHD levels of exclusively breastfed infants significantly rise at 6 months of age when their mothers are orally supplemented with 60,000 IU of vitamin D3 daily for 10 days in the early postpartum period in comparison to infants of vitamin D3 unsupplemented mothers.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>29027817</pmid><doi>10.1089/bfm.2016.0164</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1556-8253 |
| ispartof | Breastfeeding medicine, 2017-12, Vol.12 (10), p.621-628 |
| issn | 1556-8253 1556-8342 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1951561077 |
| source | Alma/SFX Local Collection |
| subjects | Age Breastfeeding & lactation Double-blind studies Evidence-based medicine Postpartum period Vitamin D Vitamin deficiency |
| title | Oral Supplementation of Parturient Mothers with Vitamin D and Its Effect on 25OHD Status of Exclusively Breastfed Infants at 6 Months of Age: A Double-Blind Randomized Placebo Controlled Trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T20%3A12%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20Supplementation%20of%20Parturient%20Mothers%20with%20Vitamin%20D%20and%20Its%20Effect%20on%2025OHD%20Status%20of%20Exclusively%20Breastfed%20Infants%20at%206%20Months%20of%20Age:%20A%20Double-Blind%20Randomized%20Placebo%20Controlled%20Trial&rft.jtitle=Breastfeeding%20medicine&rft.au=Naik,%20Prasanna&rft.date=2017-12&rft.volume=12&rft.issue=10&rft.spage=621&rft.epage=628&rft.pages=621-628&rft.issn=1556-8253&rft.eissn=1556-8342&rft_id=info:doi/10.1089/bfm.2016.0164&rft_dat=%3Cproquest_cross%3E1976080366%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1976080366&rft_id=info:pmid/29027817&rfr_iscdi=true |